Persistent lower-face breakouts in adult female patients are commonly linked to hormonal acne patterns rather than surface-level skincare factors alone. In Singapore, many women continue experiencing adult acne, particularly along the chin and jawline, where cyclical hormonal fluctuations may drive recurrent inflammation.
Hormonal acne is the most common presentation of adult acne in Singapore, particularly in women aged 20 to 45. It is consistently undertreated because it is mistaken for ordinary acne and managed with surface-level products.
In contrast, others experience persistent breakouts associated with underlying conditions such as polycystic ovary syndrome (PCOS).
Depending on the clinical presentation, treatment may include hormonal evaluation, anti-androgen therapy such as spironolactone, selected combined oral contraceptive formulations, or other dermatologist-directed treatment pathways tailored to acne severity, recurrence pattern, scarring risk, and long-term hormonal control.
DermAlly’s MOH-accredited consultant dermatologists provide diagnosis, in-clinic hormone testing where indicated, and evidence-based hormonal treatment calibrated to the patient’s life stage, fertility plans, and medical history.
Reviewed By:
What is hormonal acne? It is a form of acne in which androgen activity at the sebaceous glands drives excess oil production, follicular plugging, and the formation of inflammatory lesions.
It is a type of acne that commonly affects adult females between the ages of 20 and 45, including adolescents, postpartum women, perimenopausal women, and selected adult men. In Singapore, persistent adult acne in women is frequently linked to hormonal fluctuations rather than surface-level skincare factors alone.
The most recognisable clinical clues are a lower-face distribution and a cyclical flare pattern linked to the menstrual cycle. Female patients with jawline acne, chin breakouts, and recurrent acne along the lower cheeks commonly demonstrate a hormonally driven acne pattern.
When diagnosed correctly, hormonal acne is highly treatable. However, standard surface-acting topical treatments alone are often insufficient, particularly in patients with cyclical or treatment-resistant acne. Treatment for hormonal acne in Singapore typically targets the underlying hormonal driver rather than surface inflammation alone.
Many adult females with hormonal acne have normal androgen levels on blood testing in Singapore. In these patients, the issue is often not androgen excess, but increased sensitivity of the sebaceous gland androgen receptors. Even normal hormone levels can stimulate excess sebum production in genetically predisposed individuals.
As a result, patients with classic lower-face or cyclical acne patterns may still benefit from anti-androgen treatment despite having normal hormone test results. Therefore, hormonal acne should not be excluded based on a normal androgen panel alone, particularly in female patients with persistent jawline acne or treatment-resistant adult acne.
A smaller subset of patients does have elevated androgen levels. In women, this is most commonly linked to PCOS acne. Less common causes of hormonal acne include late-onset congenital adrenal hyperplasia.
In men, anabolic steroid use and testosterone replacement therapy may contribute to hormonally driven acne and require further endocrine evaluation.
Many women notice that their skin worsens in the week before their period. This is not a coincidence. As oestrogen and progesterone fall in the days before menstruation, androgens are left relatively unchecked, and that shift is often enough to trigger fresh inflammation along the jawline or chin. This increases sebaceous gland activity, stimulates excess oil production, and contributes to inflammatory breakouts along the lower face.
For many patients, this cyclical pattern is one of the clearest clinical clues that acne is hormonally driven rather than bacterial or surface-level.
Acne linked to polycystic ovary syndrome (PCOS) is associated with chronically elevated androgen levels and is one of the most common endocrine causes of persistent acne in women. PCOS acne can also be inflammatory and cystic.
In addition, patients may experience irregular or absent menstrual periods, thinning of scalp hair, excess facial or body hair growth, acanthosis nigricans (a darkening and thickening of the skin commonly seen around the neck, underarms, or groin), and weight gain.
When the clinical picture suggests an underlying hormonal disorder, evaluation may include clinical assessment for hyperandrogenism, hormone blood testing for acne, and pelvic ultrasound, where indicated.
Rapid hormonal shifts during pregnancy can trigger acne flares, particularly during the first and second trimesters. Some patients develop acne for the first time during pregnancy, while others experience worsening of pre-existing hormonally driven breakouts.
In certain patients, acne improves during the third trimester or after delivery. In others, inflammatory lower-face acne may persist throughout pregnancy and into the postpartum period.
Treatment options during pregnancy are more limited because several commonly used acne medications are contraindicated. Management, therefore, focuses on pregnancy-safe topical therapies and careful treatment selection.
After delivery, hormones drop sharply and quickly. For many women, that crash is enough to bring on a wave of acne, sometimes for the first time in their lives. The sharp decline in pregnancy hormones, combined with the relative androgen influence associated with breastfeeding, may stimulate sebaceous gland activity and inflammatory breakouts.
Some women experience acne for the first time after childbirth, while others notice worsening of pre-existing hormonal acne. Lower-face inflammatory lesions and recurrent jawline breakouts are common during this period.
Treatment must be carefully adjusted according to breastfeeding status, as several oral and topical acne medications remain unsuitable during lactation.
Declining oestrogen levels during perimenopause and menopause create a relative increase in androgen influence within the skin. As a result, some women develop perimenopausal acne in their late 40s or 50s, while others experience the return of acne after years of clear skin. This may occur alongside increased skin dryness, sensitivity, or changes in skin texture associated with hormonal ageing.
Women in this life stage are often overlooked in mainstream acne care, yet the impact of hormonal breakouts on confidence and daily life at this age is just as significant as it is for younger patients.
Stopping a combined oral contraceptive, switching to a progestin-only contraceptive, or changing to a hormonal intrauterine device (IUD) may trigger or worsen hormonally driven acne.
Some patients develop acne shortly after discontinuing birth control pills that previously suppressed androgen activity. Others experience new inflammatory breakouts after changing to contraceptive formulations with different hormonal profiles.
Patterns vary substantially depending on the specific contraceptive formulation involved, underlying androgen sensitivity, and pre-existing acne tendency.
Chronic stress may worsen hormonally influenced acne through increased cortisol production and its downstream effects on the hypothalamic-pituitary-adrenal axis. This hormonal signalling pathway regulates communication between the brain and adrenal glands.
Elevated cortisol levels may increase adrenal androgen activity, stimulate sebaceous gland function, and contribute to inflammatory signalling within the skin.
Stress-related acne flares are commonly observed during periods of prolonged psychological strain, sleep disruption, major life changes, examinations, or high-pressure work environments.
While stress alone is rarely the sole cause of hormonal acne, it frequently acts as an aggravating factor in genetically predisposed individuals.
Certain medications and supplements may trigger or worsen hormonal acne. These include:
Some people are simply more prone to hormonal acne than others. Genetics influences how sensitively the sebaceous glands respond to androgens, how intensely the skin inflames, and how readily it scars. A strong family history is common in patients with persistent adult acne and recurrent lower-face breakouts.
Genetics may also influence how strongly sebaceous glands respond to otherwise normal circulating androgen levels. This helps explain why some patients develop significant hormonal acne despite normal hormone levels on blood tests.
Male hormonal acne is less common than female hormonal acne but remains clinically important. Contributing factors include puberty, anabolic steroid use, testosterone replacement therapy, late-onset endocrine disorders, and genetic sebaceous gland sensitivity.
In adult men, hormone-driven acne may present with persistent inflammatory lesions on the jawline, chest, shoulders, and back. Acne associated with anabolic steroid use is often severe and truncal.
Treatment differs from female hormonal acne. Spironolactone for acne is generally not used in men because of its anti-androgen effects, and endocrine evaluation may be required where underlying hormonal pathology is suspected.
Several acne conditions can appear clinically similar despite having different underlying causes. Understanding the differences among hormonal, bacterial, and fungal acne is important because patients may present with overlapping patterns, and treatment responses vary significantly among these conditions.
In some patients, hormonally driven breakouts may coexist with fungal folliculitis affecting the chest or upper back. Other patients may develop severe cystic acne requiring escalation to isotretinoin, particularly in cases with significant inflammation or scarring risk.
Feature | Hormonal Acne | Bacterial Acne | Fungal Acne |
Primary Driver | Androgen-driven sebum production | Cutibacterium acnes proliferation with follicular plugging | Malassezia yeast overgrowth |
Typical Location | Jawline Chin Lower cheeks Neck (U-shaped pattern) | Forehead T-zone Cheeks Variable distribution | Forehead Hairline Chest Upper back Shoulders |
Lesion Type | Deep, tender nodules and cysts | Mixed comedones, papules, and pustules | Uniform small papules and pustules |
Pattern | Cyclical, linked to hormonal fluctuations | Persistent without a clear cyclical link | Often worsens with heat, humidity, and antibiotics |
Symptom | Tender or painful | Tender or painful | Commonly itchy |
Response to Oral Antibiotics | Variable or limited | Often improves | Often ineffective or worsening |
Response to Anti-Androgen Therapy | Often effective | Limited | Ineffective |
Response to Antifungal Therapy | Ineffective | Often ineffective | Effective |
Persistent lower-face breakouts, cyclical acne flares, or treatment-resistant adult acne may require more than standard topical treatment alone.
DermAlly’s Consultant Dermatologists can assess your hormonal acne and recommend a tailored treatment plan. Book a consultation today.
Several acne conditions can appear clinically similar despite having different underlying causes. Understanding the differences among hormonal, bacterial, and fungal acne is important because patients may present with overlapping patterns, and treatment responses vary significantly among these conditions.
In some patients, hormonally driven breakouts may coexist with fungal folliculitis affecting the chest or upper back. Other patients may develop severe cystic acne requiring escalation to isotretinoin, particularly in cases with significant inflammation or scarring risk.
Several inflammatory skin conditions are commonly mistaken for hormonal acne, particularly in adults with persistent lower-face breakouts. DermAlly’s consultant dermatologists assess for overlapping or alternative diagnoses before initiating treatment.
Singapore’s climate and lifestyle factors may contribute to the persistence and severity of hormonal acne. The combination of chronic humidity, dietary influences, and prolonged lower-face occlusion commonly overlaps with hormonally driven breakouts in adult patients.
The country’s year-round humidity, typically ranging from 75% to 85%, may increase sebaceous gland activity and worsen follicular plugging during hormonal acne flares. Many patients notice increased oiliness and inflammatory breakouts during prolonged periods of heat and perspiration.
Dietary patterns may also contribute to triggering hormonal acne in selected individuals. High-glycaemic foods and beverages commonly consumed in Singapore, including white rice, bubble tea, and sweetened drinks, may influence insulin and insulin-like growth factor-1 (IGF-1) signalling pathways involved in sebaceous gland activity. High dairy intake may also aggravate acne in predisposed patients.
In healthcare, food service, and other mask-dependent occupations, prolonged mask wear may contribute to lower-face occlusion and friction. This frequently overlaps with the jawline and chin distribution seen in hormonal acne.
Asian skin types, particularly Fitzpatrick III–V, are also more prone to post-inflammatory hyperpigmentation (PIH) following acne inflammation. In many patients, pigmentation affecting the jawline and lower face may persist for months after active acne lesions have resolved.
Consultation begins with a detailed clinical history and skin examination to identify hormonal patterns, severity, and possible underlying endocrine contributors.
This includes assessment of:
A clinical examination typically includes the evaluation of:
Several inflammatory skin conditions may mimic hormonal acne, particularly in adults with persistent lower-face breakouts.
Assessment may include exclusion of:
Where clinically indicated, hormone testing for acne may be performed to assess for underlying endocrine abnormalities. This may include:
Where applicable, testing is timed to days two to five of the menstrual cycle. Cortisol and androgen testing are typically performed using morning blood samples.
Treatment for hormonal acne is calibrated according to acne severity, scarring risk, life stage, fertility plans, and medical history. In many patients, standard surface-level topical treatment alone is insufficient because the underlying hormonal driver remains active.
For moderate to severe presentations, hormonal therapy often forms the clinical core of treatment. Some patients may also require oral antibiotics, procedural treatment, or escalation to isotretinoin for hormonal acne where significant cystic acne or scarring is present.
Several clinical patterns commonly suggest hormonal acne rather than surface-level or adolescent acne.
Topical treatment may be appropriate for mild to moderate hormonal acne or as part of combination therapy alongside oral medication.
The principal anti-androgen used in adult female hormonal acne. Spironolactone reduces androgen activity at the sebaceous gland and is commonly prescribed for persistent lower-face inflammatory acne in women.
Dosing is gradually escalated under specialist supervision, with full treatment response often taking three to six months.
Important considerations may include:
Spironolactone is generally not used in men because of its anti-androgen effects.
Selected formulations of combined oral contraceptives for acne help regulate hormonal fluctuations and reduce free androgen activity by increasing sex hormone-binding globulin (SHBG). Certain formulations may provide additional skin benefit in women with cyclical hormonal acne patterns.
Combined oral contraceptives are not suitable for all patients and may be contraindicated in those with:
Oral antibiotics such as doxycycline or minocycline may be used as short-term bridging therapy while hormonal acne treatment reaches full clinical effect. These medications are typically prescribed for 3 months or less to reduce inflammatory activity during active acne flares. They are commonly combined with benzoyl peroxide to reduce the risk of bacterial resistance.
As both doxycycline and minocycline may increase photosensitivity, sun protection is particularly important in Singapore’s climate, especially in patients with prolonged outdoor exposure.
Isotretinoin for hormonal acne may be indicated in patients with severe cystic acne, significant scarring, or inadequate control despite hormonal therapy and oral antibiotics.
Isotretinoin dramatically reduces sebaceous gland activity and alters follicular biology more profoundly than conventional topical treatments. Treatment courses typically last six to nine months under a dermatologist’s supervision.
Strict pregnancy precautions apply because isotretinoin is highly teratogenic. Patients require reliable contraception throughout treatment and for one month after completion.
Monitoring typically includes:
Common side effects include:
Selected in-clinic procedures may be used alongside medical treatment to address painful cysts, residual pigmentation, redness, or acne scarring.
Many medications commonly used for hormonal acne are not considered safe during pregnancy or breastfeeding. Treatment, therefore, requires careful adjustment according to pregnancy status, fertility plans, and whether the patient is actively breastfeeding.
The following treatments are generally avoided or contraindicated during pregnancy:
Options suitable for patients who are pregnant or breastfeeding include:
Pregnancy, breastfeeding, or pre-conception planning should be disclosed during consultation so treatment can be adjusted appropriately. In postpartum patients, selected treatments may be gradually reintroduced based on breastfeeding status and overall clinical suitability.
Declining oestrogen levels during perimenopause and menopause lead to a relative increase in androgen influence on the sebaceous gland. As a result, some women develop perimenopausal acne for the first time in their late 40s or 50s, while others experience the return of hormonally driven breakouts after decades of clear skin.
Breakouts commonly affect the jawline, chin, and lower face, and may occur alongside increased skin dryness or sensitivity associated with hormonal ageing.
Spironolactone is frequently effective in this age group and is generally well tolerated when appropriately monitored. In many patients, treatment helps reduce persistent lower-face inflammatory lesions linked to androgen activity.
Hormone replacement therapy (HRT) may also influence acne patterns. Certain oestrogen formulations may improve hormonally driven acne, while selected progestins may worsen it. Depending on the clinical picture, co-management with the patient’s gynaecologist may be appropriate.
Combined oral contraceptives are generally not used in this demographic because thrombotic risk increases with age.
Although less common than female hormonal acne, late-onset or persistent inflammatory acne in adult men may warrant further assessment. Severe acne developing suddenly in a previously clear-skinned man, or acne persisting into the 30s and 40s, may suggest an underlying hormonal contributor.
Potential drivers include anabolic steroid use, testosterone replacement therapy, supraphysiological testosterone dosing, and selected endocrine disorders. In some patients, hormonally influenced acne may affect the jawline, chest, shoulders, and back, with significant inflammatory or cystic involvement.
Spironolactone is generally not used in men because of its anti-androgen and feminising effects at therapeutic doses.
Treatment may include:
Where relevant, contributing supplementation, anabolic steroid use, or hormone therapy may also require modification as part of the broader treatment plan.
Disclosure of supplement use, testosterone therapy, and performance-enhancing substances during consultation is important because these factors may significantly influence acne severity and treatment response.
In Asian skin types, particularly Fitzpatrick III–V, hormonal acne carries a higher risk of post-inflammatory hyperpigmentation (PIH), especially along the jawline and lower face. Even after active acne lesions resolve, residual pigmentation may persist for months and, in many patients, becomes more visually prominent than the acne itself.
Patients with cystic or deeply inflammatory hormonal acne may also develop atrophic acne scars, including icepick, boxcar, and rolling scars. In predisposed individuals, recurrent inflammation may additionally trigger raised hypertrophic or keloid scarring.
Early control of hormonally driven acne remains the most effective strategy for reducing the risk of long-term pigmentation and scarring. Where acne scars are already present, is typically staged after active acne has been medically stabilised.
For severe hormonal acne with significant cystic inflammation, scarring, or treatment-resistant disease, DermAlly works closely with sister practice The Acne Clinic, led by Dr Ramita Kaur Shahi and dedicated to acne management.
Referral may be appropriate for selected patients requiring escalation of care for complex cystic acne, advanced scar management, or highly resistant inflammatory acne.
Singapore’s healthcare advertising regulations under the Private Hospitals and Medical Clinics (PHMC) Act and Healthcare Services Act (HCSA) restrict the use of before-and-after photography in medical advertising. DermAlly fully adheres to these guidelines.
During consultation, DermAlly’s consultant dermatologists explain expected treatment timelines, discuss realistic clinical outcomes, and review management strategies based on the patient’s hormonal acne pattern, life stage, and medical history. Where appropriate, peer-reviewed clinical literature may also be referenced to support treatment counselling.
Three MOH-accredited Consultant Dermatologists lead DermAlly’s hormonal acne service with combined experience across academic institutions, public hospitals, and private dermatology practices. Assessment focuses not only on acne severity, but also on identifying the underlying hormonal driver and excluding overlapping conditions commonly mistaken for hormonal acne, including perioral dermatitis, rosacea, fungal folliculitis, and bacterial folliculitis.
Where clinically indicated, DermAlly also provides in-clinic hormone testing for acne, including cycle-timed and morning-timed blood sampling for a more clinically meaningful hormonal assessment.
Treatment capability spans topical therapy, spironolactone, combined oral contraceptives, and isotretinoin for hormonal acne, with co-management pathways available for patients with PCOS, perimenopausal acne, or other endocrine-related presentations.
DermAlly operates from two locations in Singapore: Camden Medical Centre in Orchard and i12 Katong on the East Coast. For severe cystic or treatment-resistant acne, patients may also be referred to sister practice The Acne Clinic for additional specialist acne management where appropriate.
Consultation for hormonal acne begins with a comprehensive clinical assessment covering acne onset, distribution, cyclical flare patterns, menstrual and reproductive history, contraceptive use, pregnancy and breastfeeding status, previous treatments, family history, supplement use, and current skincare routines.
Physical examination includes evaluation of acne morphology, severity, scarring risk, and signs of hyperandrogenism such as excess facial hair growth, scalp hair thinning, or acanthosis nigricans.
Where clinically indicated, further diagnostic workup may include:
Treatment is then staged according to acne severity, hormonal pattern, scarring risk, life stage, and medical history. Patients are advised on realistic timelines, with early response to hormonal therapy commonly seen within eight to 12 weeks and fuller treatment effect often requiring three to six months alongside maintenance therapy.
#05-01/02
1 Orchard Boulevard
Singapore 248649
Clinic: +65 6331 6988
WhatsApp: +65 8939 7388
Mon – Fri: 9 am – 5 pm
Sat:9 am – 1 pm
Closed on Sunday
#03-08
112 East Coast Road
Singapore 428802
Clinic: +65 6331 6988
WhatsApp: +65 9727 6928
Mon: Closed
Tues – Fri: 9 am- 6 pm
Sat/Sun: Closed
Common side effects are redness, swelling, and temporary changes in pigmentation, which typically resolve within a few days to weeks. Your dermatologist will inform you about potential side effects based on the chosen treatment.
Book an appointment with our expert dermatologists. Please select your preferred clinic below.
